Join our webinar
Characterizing formulations, drug targets and viruses
with Small-Angle X-ray Scattering
Tuesday October 27, 9:30 - 10:15 am CET
Friday October 30, 4:00 - 4:45 pm CET
The global COVID-19 pandemic stresses the necessity to accelerate the different stages of drug development, reduce drug candidate attrition rates and establish solid testing protocols to ensure that only safe and stable formulations enter the market. Small and Wide Angle X-ray Scattering (SAXS and WAXS) can help tackle several of these challenges by offering a fast and robust protocol to analyze the structure, morphology and interactions in the involved systems.
In this talk we show how SAXS and WAXS facilitate research, development and quality control at the various stages of drug and vaccine development. Starting with the role SAXS can play for drug and vaccine target discovery, followed by the SAXS analysis of viruses. We highlight how high-throughput screening accelerates preclinical development and finally, how SAXS can function as a fingerprint technique for troubleshooting, manufacturing monitoring and quality control.
The webinar will take 30 minutes with a live 15 minute Q&A afterwards.
Speaker: Dr Isja de Feijter, Xenocs.
We look forward to meeting you online!
Session 1: Europe, Africa and Asia
Tuesday, Oct. 27 – 9:30 – 10:15 am CET
Session 2: Europe, North and South America
Friday, Oct. 30 – 4:00 – 4:45 pm CET
Session 1: Oct 27, 9:30-10:15 am Central European Time, 4:30-5:15 pm Beijing Time, 2:00-2:45 pm Dehli Time.
Session 2: Oct 30, 4:00-4:45 pm CET, 11:00-11:45 am Eastern Daylight Time, 8:00-8:45 am Pacific Time.
Further reading
White paper - SAXS for drug development and formulations
Relevant publications from our customers
- Studying Excipient Modulated Physical Stability and Viscosity of Monoclonal Antibody Formulations Using Small-Angle Scattering, DOI:10.1021/acs.molpharmaceut.9b00687
- Antigenic and physicochemical characterization of Hepatitis B surface protein under extreme temperature and pH conditions, DOI:10.1016/j.vaccine.2019.09.005
- Nanostructured SBA-15 silica: An effective protective vehicle to oral hepatitis B vaccine immunization, DOI:10.1016/j.nano.2016.06.003
- X-ray Scattering and Coarse-Grained Simulations for Clustering and Interactions of Monoclonal Antibodies at High Concentrations, DOI:10.1021/acs.jpcb.9b04478
- Liquid Crystalline Nanoparticles as an Ophthalmic Delivery System for Tetrandrine: Development, Characterization, and In Vitro and In Vivo Evaluation, DOI:10.1186/s11671-016-1471-0
